Resistance to third-generation cephalosporins and other antibiotics by Enterobacteriaceae in Western Nigeria

American Journal of Infectious Diseases

Volumn 5, Issue 1, 2009, Pages 17-20

  Okesola, A O ^a   Makanjuola, O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Enterobacteriaceae; Resistance; Third generation cephalosporins

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; FEMALE; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NIGERIA; NONHUMAN; PROTEUS;

EID: 64549096462     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2009.17.20     Document Type: Article

References (16)

1. Kumar, M.S., V. Lakshmi and R. Rajagopalan, 2006. Occurrence of extended-spectrum beta-lactamases among Enterobacteriacea spp. isolated at a tertiary care institute. Ind. J. Med. Micro., 24: 208-211. http://www.bioline.org.br/request?mb06060
2. Paterson, D., 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Inform. Control, 34: 520-528. http://linkinghub.elsevier.com/retrieve/pii/S0196655306008534
3. Bronson, J.J. and J.F. Barrett, 2001. Quinolone, eveminomycin, glycylcycline, carbapenem, lipopeptide and Cephem. Antibacterials in clinical development. Curr. Med. Chem., 8: 1775-1793. DOI: 10.2174/ 0929867013371653
4. Medeiros, A.A., 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis., 24: S19-S45. http://www.ncbi.nlm.nih.gov/pubmed/8994778
5. Jacoby, G.A. and A.A. Medeiros, 1991. More extended-spectrum β-lactamases. Antimicrob Agents Chemother., 35: 1697-1704. http://aac.asm.org/cgi/reprint/35/9/1697
6. Girlich, D., L. Poireland and A. Leelaporn et al., 2001. Molecular epidemiology of the integron-locatedVEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol., 39: 175-182. DOI: 101128/ JCM.391.175-182.2001
7. Knothe, H., P. Shah, V. Kremery, M. Antal and S. Mitsuhashi, 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection, 11: 315-317. DOI: 10.1007/ BF01641355
8. George, A., M.D. Jacoby and Luisa Silvia Munoz-Price, 2005. The new β-lactamases. N. Engl. J. Med., 352: 380-391. http://content.nejm.org/cgi/content/full/352/4/380
9. Bradford, P.A., 2001. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin. Microbiol. Rev., 14: 933-951. DOI: 10.1128/ CMR.14.4.933-951.2001
10. Kliebe, C., B.A. Nies, J.F. Meyer, R.M. Tolxdorff-Neutzling and B. Weidemann, 1985. Evolution of plasmid coded resistance to broad spectrum cephalosporins. Antimicrob. Agents Chemother., 28: 302-307. http://aac.asm.org/cgi/content/abstract/28/2/302
11. Burwen, D.R., S.N. Banerjee and R.P. Gaynes, 1994. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J. Infect. Dis., 170: 1622-1625. http://cat.inist.fr/ ?aModele=afficheN&cpsidt=3336301
12. Qin, D., S.J. Weissman and M.F. Chestnut et al., 2004. Kirby-bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae. Ann. Clin. Microbiol. Antimicrobl., 3:13-13 DOI: 10.1186/1476-0711-3-13
13. Spanu, T., F. Luzzano, M. Perilli, Q. Amicosante, A. Toniolo and G. Fadda, 2002. Italian ESBLs study group. Occurrence of Extended spectrum β-lactamases in members of family enterobacteriaceae in Italy. Implication of resistance to β-lactams and other antimicrobial agents. Antimicrob. Agents Chemother., 46: 196-202. DOI: 10.1128/ AAC.461.196-202.2002
14. Burgess, D.S. and R.G. Hall, 2004. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-esbl producing Klebsiella pneumoniae. Diagnst. Microbiol. Inf. Dis., 49: 41-46. DOI: 10.1016/ j.diagmicrobio.2003.11.007
15. Paterson, D.L., W.C. Ko and A. VanGottberg et al., 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol., 39: 2206-2212. DOI: 10.1128/JCM.39.6.2206-2212.2001
16. Endimiani, A., F. Luzzaro and M. Perilli et al., 2004. Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum β-lactamase: Treatment outcome of patients receiving imipenem or ciprofloxacin. Clin. Infect. Dis., 38: 243-251. DOI: 10.1086/380645